Popular Trials
Efruxifermin for Nonalcoholic Steatohepatitis
Recruiting0 awardsPhase 2
Marrero, Louisiana
This trial is testing a medication called efruxifermin to see if it can help people with a specific liver disease called NASH. The study focuses on patients whose disease has not yet progressed to cirrhosis. The medication works by reducing inflammation and fat in the liver to improve its health.
Corticosteroid
Miricorilant for Non-Alcoholic Steatohepatitis
Recruiting0 awardsPhase 2
Hialeah Gardens, Florida
This trial is testing a medication called miricorilant to see if it can help adults with a liver disease called NASH. The medication aims to reduce fat and inflammation in the liver. About 150 patients will take either miricorilant or another treatment for several months.
Glucagon-like peptide-1 (GLP-1) receptor agonist
Pemvidutide for Nonalcoholic Steatohepatitis (NASH)
Recruiting0 awardsPhase 2
Fort Myers, Florida
This trial is testing pemvidutide, a medication that may help treat NASH, a liver disease. It aims to see if the drug can reduce liver damage and help the liver heal.
HTD1801 for Non-alcoholic Fatty Liver Disease
Recruiting0 awardsPhase 2
Waco, Texas
This trial is testing HTD1801, a medication, to see if it can help adults with NASH and liver fibrosis who also have type 2 diabetes or pre-diabetes. The goal is to see if the medication can reduce liver inflammation and scarring, thereby improving liver health.
Popular Filters
Trials for Non-alcoholic Fatty Liver Disease Patients
Efinopegdutide for Nonalcoholic Steatohepatitis (NASH)
Recruiting0 awardsPhase 2
Hialeah, Florida
This trial is testing a new medicine called efinopegdutide to see if it can help people with a liver disease called non-alcoholic steatohepatitis (NASH). Researchers want to find out if this medicine can reduce the symptoms of NASH without making liver scarring worse. They are also checking how safe the medicine is and how well people can tolerate it.
Trials for NAFLD Patients
Efinopegdutide for Nonalcoholic Steatohepatitis (NASH)
Recruiting0 awardsPhase 2
Hialeah, Florida
This trial is testing a new medicine called efinopegdutide to see if it can help people with a liver disease called non-alcoholic steatohepatitis (NASH). Researchers want to find out if this medicine can reduce the symptoms of NASH without making liver scarring worse. They are also checking how safe the medicine is and how well people can tolerate it.
Trials With No Placebo
Procedure
Surgical vs. Lifestyle Interventions for Type 2 Diabetes
Recruiting1 award5 criteria
Pittsburgh, Pennsylvania
This trial is being done to compare the effectiveness of two types of bariatric surgery against an intensive lifestyle intervention in promoting weight loss and improvements in Type 2 diabetes in moderately obese patients.
Behavioral Intervention
Exercise Program for Fatty Liver Disease
Recruiting1 award5 criteria
Hershey, Pennsylvania
"This trial will test a new exercise program called EL-FIT on patients with a liver condition. The goal is to see if the program is safe and effective for patients with nonalcoholic steatohe
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.